Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mpex Pharmaceuticals Inc.

Division of Allergan PLC
www.mpexpharma.com

Latest From Mpex Pharmaceuticals Inc.

Venture Funding Deals: Gotham Raises $54m To Advance Epitranscriptomics

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced September and October 2018.
Deals Financing

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Repeat antibiotic entrepreneurs raised $33m to launch Qpex with assets from The Medicines Co. Also, Taiho increases VC fund to $300m and TP Therapeutics raises $80m.

Financing StartUps and SMEs

Circle Of Life: Raptor Buys Quinsair After Its Return To Original Developer

Quinsair (inhaled levofloxacin) – originally known as Aeroquin – took a circuitous route to its new home at Raptor Pharmaceuticals, which will pay Tripex Pharmaceuticals $68.4m up front and up to $350m in milestone fees plus a small royalty for the cystic fibrosis (CF) drug.

Gastrointestinal Orthopedics

With Ikaria and Aptalis, Private Equity Investors Get Creative To Cash Out

Ikaria shareholders sold the commercial side of that critical care business, but retained a stake in the off-loaded assets. While gastrointestinal and cystic fibrosis company Aptalis turns to an IPO instead of an acquisition.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Daniel D Burgess, Pres. & CEO
    Dana Krzyston, VP, Fin. & Operations
    Michael N Dudley, SVP, R&D & CSO
  • Contact Info
  • Mpex Pharmaceuticals Inc.
    Phone: (858) 875-2840
    11535 Sorrento Valley Rd.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register